{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:12:00Z","timestamp":1783440720817,"version":"3.54.6"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Project of Administration of Traditional Chinese Medicine in Zhejiang Province of China","award":["2020ZB189, 2024ZL697"],"award-info":[{"award-number":["2020ZB189, 2024ZL697"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>This study aims to assess the diagnostic value of drug withdrawal for drug-induced liver injury (DILI). Seventeen cases of suspected DILI were retrospectively analyzed at the time of initial diagnosis. Pertinent patient demographics such as gender, age, suspected causative drugs, initial serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) levels, and additional clinical parameters were documented. Subsequently, the suspected drugs were discontinued without the administration of liver-protective interventions, and the hepatic function of the patients was reassessed weekly. Based on the criteria of whether serum ALT\/AST levels decreased by more than 50% from their respective baseline values after 1 week, patients were categorized into either the rapid decline group or the non-rapid decline group. This observation period was extended for 4 weeks, succeeded by a subsequent follow-up period of 4 weeks. Most patients recovered liver function within 3 weeks after drug withdrawal. The rapid decline group (12\/12) recovered fully, compared to 4\/5 in the non-rapid group. Liver enzyme levels (ALT\/AST) differed significantly between groups over 4 weeks, with the rapid group showing a larger initial AST drop. All other factors like age and gender were similar. The time to disease recurrence was also comparable. A high DILI probability was confirmed in 16 of the 17 suspected cases, indicating a 94.11% diagnostic accuracy for DILI. In conclusion, this retrospective analysis underscores the potential of drug withdrawal as an effective management strategy for suspected DILI. The findings reveal that the cessation of suspected causative drugs, without the administration of liver-protective treatment, leads to recovery in hepatic function, as evidenced by the normalization of serum ALT and AST levels, contributing to the diagnosis of DILI.<\/jats:p>","DOI":"10.1097\/md.0000000000047340","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:02:41Z","timestamp":1769965361000},"page":"e47340","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of drug withdrawal observation in drug-induced liver injury: A retrospective study"],"prefix":"10.1097","volume":"105","author":[{"given":"Yi-Hui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Third Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-20260519","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.4103\/jpbs.jpbs_568_25","article-title":"Drug-induced liver injury: mechanisms, diagnosis, and management: a review.","volume":"17","author":"Keshari","year":"2025","journal-title":"J Pharm Bioallied Sci"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00018-025-05744-3","article-title":"Mechanisms of drug induced liver injury.","volume":"82","author":"Skat-R\u00f8rdam","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"e16146","DOI":"10.1111\/liv.16146","article-title":"Epidemiology and risk determinants of drug-induced liver injury:current knowledge and future research needs.","volume":"45","author":"Suzuki","year":"2025","journal-title":"Liver Int"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/1751-2980.13337","article-title":"Chinese guideline for the diagnosis and management of drug-induced liver injury in primary care (2024).","volume":"26","author":"Mao","year":"2025","journal-title":"J Dig Dis"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A prospective nationwide study of drug-induced liver injury in Korea.","volume":"107","author":"Suk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40264-024-01486-6","article-title":"Incidence of idiosyncratic drug-induced liver injury caused by prescription drugs.","volume":"48","author":"Chen","year":"2025","journal-title":"Drug Saf"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic.","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40264-017-0547-9","article-title":"The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of delaware.","volume":"40","author":"Vega","year":"2017","journal-title":"Drug Saf"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"e16083","DOI":"10.1111\/liv.16083","article-title":"Methods for causality assessment of idiosyncratic drug-induced liver injury.","volume":"45","author":"Garc\u00eda-Cort\u00e9s","year":"2025","journal-title":"Liver Int"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1111\/liv.70019","article-title":"Drug-induced liver injury in patients with chronic liver disease.","volume":"45","author":"Ghabril","year":"2025","journal-title":"Liver Int"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"e16097","DOI":"10.1111\/liv.16097","article-title":"Role of liver biopsy in the management of idiosyncratic DILI.","volume":"45","author":"Kleiner","year":"2025","journal-title":"Liver Int"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17425255.2025.2495955","article-title":"DILI prediction in drug development: present and future.","volume":"21","author":"Uetrecht","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R15-20260519","first-page":"810","article-title":"Guidelines for diagnosis and treatment of drug-induced liver injury.","volume":"23","year":"2015","journal-title":"Chin J Liver Dis"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury.","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury.","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dld.2022.06.025","article-title":"Sex disparity and drug-induced liver injury.","volume":"55","author":"Floreani","year":"2023","journal-title":"Dig Liver Dis"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clinre.2017.08.003","article-title":"Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.","volume":"42","author":"Pang","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2468-1253(20)30006-6","article-title":"Drug-induced liver injury in older people.","volume":"5","author":"Lucena","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.3390\/ijms231810654","article-title":"The role of sex in acute and chronic liver damage.","volume":"23","author":"Sayaf","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"939631","DOI":"10.3389\/fimmu.2022.939631","article-title":"The hepatoprotective and hepatotoxic roles of sex and sex-related hormones.","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/CS20171260","article-title":"Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury.","volume":"132","author":"Bizzaro","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"R25-20260519","first-page":"69","article-title":"Clinical characteristics of drug-induced liver injury in different sex patients.","volume":"25","author":"Ma","year":"2023","journal-title":"J Adverse Drug React"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.","volume":"75","author":"Stephens","year":"2021","journal-title":"J Hepatol"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cgh.2020.06.067","article-title":"A high serum level of taurocholic acid is correlated with the severity and resolution of drug-induced liver injury.","volume":"19","author":"Tian","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"8096847","DOI":"10.1155\/2020\/8096847","article-title":"Gender difference on the effect of omega-3 polyunsaturated fatty acids on acetaminophen-induced acute liver failure.","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/hepr.13288","article-title":"Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan.","volume":"49","author":"Aiso","year":"2019","journal-title":"Hepatol Res"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in Mainland China.","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"R31-20260519","first-page":"1165","article-title":"Chinese herbal medicine related liver injury clinical guidelines.","volume":"41","year":"2016","journal-title":"Chin J Tradit Chin Med"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30660","article-title":"HLA-B*35:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans.","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"806249","DOI":"10.3389\/fphar.2021.806249","article-title":"Pharmacotherapies for drug-induced liver injury: a current literature review.","volume":"12","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/biomedicines11010015","article-title":"Treatment of drug-induced liver injury.","volume":"11","author":"Teschke","year":"2022","journal-title":"Biomedicines"},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/liv.14204","article-title":"Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: a phase II trial.","volume":"39","author":"Wang","year":"2019","journal-title":"Liver Int"},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/liv.15290","article-title":"Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: a multicenter, randomized, phase II trial.","volume":"42","author":"Tang","year":"2022","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:05:34Z","timestamp":1779195934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047340","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}